Exane Derivatives’s Fortive FTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$148K Sell
3,600
-990
-22% -$43.8K 0.08% 215
2022
Q1
$211K Sell
4,590
-1,596
-26% -$78.9K 0.06% 318
2021
Q4
$356K Sell
6,186
-4
-0.1% -$226 0.09% 230
2021
Q3
$329K Buy
6,190
+5,258
+564% +$288K 0.08% 261
2021
Q2
$49.5K Sell
932
-84
-8% -$4.53K 0.01% 651
2021
Q1
$54.1K Buy
1,016
+156
+18% +$8.07K 0.02% 508
2020
Q4
$45.9K Buy
+860
New +$44.2K 0.01% 462

Other funds holding FTV

Exane Derivatives's FTV Position: Q2 2022 in Review

Exane Derivatives reduced its Fortive (FTV) stake by 22% in Q2 2022, selling an estimated $43.8K and leaving 3,600 shares worth $148K. The position accounts for 0.08% of the portfolio, ranked #215.

Exane Derivatives first reported a position in FTV in Q4 2020 and has held it in 7 quarters since. The position peaked at $356K in Q4 2021. 727 funds tracked by Wall St. Rank hold FTV as of Q2 2022.

  • Exane Derivatives held 3,600 shares of Fortive worth $148K as of Q2 2022.
  • Exane Derivatives sold 990 Fortive shares in Q2 2022, an estimated $43.8K.
  • Fortive made up 0.08% of Exane Derivatives's portfolio in Q2 2022, its #215 holding.
  • Exane Derivatives first reported a position in Fortive in Q4 2020 and has held it in 7 quarters since.
  • Exane Derivatives's Fortive position peaked at $356K in Q4 2021.
  • 727 funds tracked by Wall St. Rank held Fortive as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.